Ph.D., Cellular and Molecular Medicine, Johns Hopkins University School of Medicine
B.S., Biology, Bridgewater State University
Galanis, A., Ma, H., Rajkhowa, T., Ramachandran, A., Small, D., Cortes, J., & Levis, M. (2014). Crenolanib is a potent inhibitor of FLT3 with activity against resistance-conferring point mutants. Blood, 123(1), 94–100.
Galanis, A., & Levis, M. (2014). Inhibition of c-kit by tyrosine kinase inhibitors. Haematologica, 100(3), e77.